Literature DB >> 16585953

Adult T cell leukemia: a tale of two T cells.

O John Semmes1.   

Abstract

Human T cell leukemia virus type 1 (HTLV-1) is the etiologic agent for the development of an aggressive hematologic neoplasia termed adult T cell leukemia/lymphoma (ATLL). Although the virus infects T cell subsets that display either CD4 or CD8 cell surface markers, the leukemic cell is exclusively of the CD4+ subtype. In the article by Sibon et al. in this issue of the JCI, the authors demonstrate that the molecular basis for clonal expansion differs between these 2 infected T cell populations (see the related article beginning on page 974). The molecular events associated with a preleukemic state, such as genomic instability, polynucleation, and cell cycle redistribution, were only observed in CD4+ T cells. This finding provides a molecular-based mechanism for the restriction of the leukemic phenotype to the CD4+ T cell subtype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585953      PMCID: PMC1421364          DOI: 10.1172/JCI28140

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

Review 1.  Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation.

Authors:  Kuan-Teh Jeang; Chou-zen Giam; Franca Majone; Mordechai Aboud
Journal:  J Biol Chem       Date:  2004-04-16       Impact factor: 5.157

2.  HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Authors:  David Sibon; Anne-Sophie Gabet; Marc Zandecki; Christiane Pinatel; Julien Thête; Marie-Hélène Delfau-Larue; Samira Rabaaoui; Antoine Gessain; Olivier Gout; Steven Jacobson; Franck Mortreux; Eric Wattel
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

3.  Accelerated G(1) phase progression induced by the human T cell leukemia virus type I (HTLV-I) Tax oncoprotein.

Authors:  F J Lemoine; S J Marriott
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

4.  Human T-lymphotropic virus type 1 oncoprotein tax promotes S-phase entry but blocks mitosis.

Authors:  Min-Hui Liang; Thomas Geisbert; Yao Yao; Steven H Hinrichs; Chou-Zen Giam
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Human T-cell leukemia virus-I tax oncoprotein functionally targets a subnuclear complex involved in cellular DNA damage-response.

Authors:  Abdelali Haoudi; Rodney C Daniels; Eric Wong; Gary Kupfer; O John Semmes
Journal:  J Biol Chem       Date:  2003-07-02       Impact factor: 5.157

6.  Infection of human T-lymphotropic virus type I to astrocytes in vitro with induction of the class II major histocompatibility complex.

Authors:  M Hirayama; T Miyadai; T Yokochi; K Sato; T Kubota; M Iida; N Fujiki
Journal:  Neurosci Lett       Date:  1988-09-23       Impact factor: 3.046

7.  The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein.

Authors:  T Yamada; S Yamaoka; T Goto; M Nakai; Y Tsujimoto; M Hatanaka
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures.

Authors:  P M Hoffman; S Dhib-Jalbut; J A Mikovits; D S Robbins; A L Wolf; G K Bergey; N C Lohrey; O S Weislow; F W Ruscetti
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Immediate effects of reversible HTLV-1 tax function: T-cell activation and apoptosis.

Authors:  K Chlichlia; G Moldenhauer; P T Daniel; M Busslinger; L Gazzolo; V Schirrmacher; K Khazaie
Journal:  Oncogene       Date:  1995-01-19       Impact factor: 9.867

10.  Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax.

Authors:  K F Copeland; A G Haaksma; J Goudsmit; P H Krammer; J L Heeney
Journal:  AIDS Res Hum Retroviruses       Date:  1994-10       Impact factor: 2.205

View more
  1 in total

1.  Khorasan Disease: Prevalence of HTLV-I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) In West Azarbaijan from 2004 to 2007.

Authors:  R Boostani; A Mellat Ardakani; H Ashrafi
Journal:  Iran Red Crescent Med J       Date:  2011-06-01       Impact factor: 0.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.